Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

Annals of Oncology - Tập 18 - Trang 1927-1934 - 2007
M. Kaufmann1, G. von Minckwitz1,2, H.D. Bear3, A. Buzdar4, P. McGale5, H. Bonnefoi6, M. Colleoni7, C. Denkert8, W. Eiermann9, R. Jackesz10, A. Makris11, W. Miller12, J.-Y. Pierga13, V. Semiglazov14, A. Schneeweiss15, R. Souchon16, V. Stearns17, M. Untch18, S. Loibl1,2
1J. W. Goethe-University, Frankfurt am Main
2German Breast Group, Neu-Isenburg/Frankfurt am Main, Germany
3Division of Surgical Oncology the Massey Cancer Center at Virginia Commonwealth University, Richmond, Virginia, USA and National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, Pennsylvania
4The University of Texas M.D. Anderson Cancer Center, Houston, Texas USA
5Early Breast Cancer Trialists' Collaborative Group, Oxford
6EORTC Breast Cancer Group, Hôpitaux Universitaires des Genéve, Geneva, Switzerland
7Istituto Europeo di Oncologia, Milan, Italy
8Charité, Institute of Pathology, Campus Mitte, Berlin
9Krankenhaus vom Roten Kreuz, Frauenklinik, München, Germany
10Universtitätsklinik für Chirurgie, Wien, Austria
11Mount Vernon Hospital, Northwood, Middlesex;
12University of Edinburgh, Western General Hospital, Edinburgh, UK
13Institut Curie, Department of Medical Oncology, Paris, France
14NN Petrov Research Inst of Oncology, St. Petersburg, Russia
15Ruprecht-Karls-Universität Heidelberg, Heidelberg
16Allgemeines Krankenhaus Hagen, Hagen, Germany
17The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA
18Helios Klinikum Berlin-Buch, Berlin, Germany

Tài liệu tham khảo